<?xml version="1.0" encoding="UTF-8"?>
<p>Key evidence needed that will affect decision-making are those related to COVID-19 immunity. Limited data have demonstrated that persons with significant disease develop neutralizing antibodies that may protect them against reinfection and reduce disease severity in the short-term, and some tests correlate with virus neutralization.
 <xref rid="ref5" ref-type="bibr">
  <sup>5</sup>
 </xref>
 <sup>,</sup>
 <xref rid="ref7" ref-type="bibr">
  <sup>7â€“9</sup>
 </xref> However, evidence is needed to define threshold for protection, duration of antibody persistence and immunity and assess interruption of transmission. Until answers are available, it is impossible to make truly informed decisions about whether those previously infected can safely travel and resume work and other activities without masks, physical distancing and other precautions.
</p>
